Press Releases

Investor E-mail Alert Service: You can automatically receive Press Release alerts via e-mail by subscribing now.

Keyword Search
 
05/23/2017
BD Board Declares Dividend
05/19/2017
BD Announces Results of Early Tenders and Amendments to Exchange Offers
05/15/2017
BD to Present at Investor Healthcare Conferences
05/12/2017
BD Announces Exercise of Option to Purchase Additional Shares by Underwriters of Public Equity Offerings Increasing Total Gross Proceeds to $4.95 Billion
05/10/2017
BD Prices Offerings of $2.25 Billion of Common Stock and $2.25 Billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock
05/09/2017
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
05/07/2017
BD Announces Offerings of $2.25 Billion of Common Stock and $2.25 Billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock
05/05/2017
BD Announces Commencement of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
05/02/2017
BD Announces Results For 2017 Second Fiscal Quarter
04/27/2017
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
04/26/2017
BD Licenses Novel Molecular Indexing Technology to Roche
04/23/2017
BD Announces Appointment Of Tom Polen As President
04/23/2017
BD To Acquire Bard For $24 Billion
04/06/2017
BD Receives FDA 510(k) Clearance for New Flow Cytometer System with Leucocount Reagent Assay
04/04/2017
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
04/04/2017
BD Completes Acquisition Of Caesarea Medical Electronics
04/03/2017
BD Launches "Power in Prevention" Program to Help Minimize Risk of Infections during Surgical Process at 2017 AORN Annual Conference
02/22/2017
BD To Present At Inaugural CECP CEO Investor Forum
02/22/2017
BD Veritor™ System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
02/21/2017
BD Partnership Honored by U.S. Chamber of Commerce Foundation at the Health Means Business National Summit with Healthy10 Award
02/20/2017
BD Demonstrates Synchronized Technology Platform at HIMSS17
02/17/2017
BD to Present at Investor Healthcare Conferences
02/16/2017
BD Initiates New Industry Alliance To Combat Rising Opioid Crisis
02/13/2017
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
02/02/2017
BD Announces Results For 2017 First Fiscal Quarter
01/26/2017
New BD Institute For Medication Management Excellence Aims To Improve Patient Safety And Outcomes Through Collaboration
01/23/2017
BD Board Declares Dividend
01/23/2017
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
01/18/2017
BD Announces Webcast of Annual Meeting of Shareholders
01/17/2017
BD Launches Reagents to Simplify Single Cell Research
01/11/2017
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
01/09/2017
BD to Present at the 35th Annual J. P. Morgan Healthcare Conference
12/15/2016
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
12/05/2016
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
12/01/2016
BD Announces Pricing of Tender Offers
12/01/2016
BD Announces Early Tender Results and Upsizing of Maximum Tender Offers
12/01/2016
BD Announces Adoption of Windows 10 'Internet of Things' for the Pyxis™ ES System
12/01/2016
BD to Offer Euro-denominated Senior Unsecured Notes
11/23/2016
BD to Present at the 28th Annual Piper Jaffray Healthcare Conference
11/21/2016
BD Board Increases Dividend
11/16/2016
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
11/14/2016
BD Announces 2016 Analyst Day And Webcast
11/10/2016
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
11/08/2016
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
11/03/2016
BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance
10/31/2016
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
10/04/2016
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
10/04/2016
BD and Apax Partners Announce Closing of Joint Venture to Launch Global Respiratory Business
09/30/2016
BD Expands Efforts To Combat Antimicrobial Resistance With New Automated ID/AST System
09/22/2016
BD Invests $100 Million In Nebraska Plant To Expand Insulin Syringe Manufacturing
09/21/2016
BD Unveils Next Generation Wireless Point-of-Care Diagnostic Device
09/17/2016
Mayo Clinic Proceedings Publishes New Insulin Injection and Infusion Recommendations
09/16/2016
BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial
09/14/2016
BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions
09/12/2016
BD Announces New Software Release For Pyxis Enterprise Solution
09/06/2016
BD to Present at the Morgan Stanley Global Healthcare Conference 2016
09/06/2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity™ HPV Test
09/01/2016
Mayo Clinic Proceedings Publishes New Insulin Injection and Infusion Recommendations
08/18/2016
BD Celebrates 60 Years In Sandy, Utah
08/16/2016
BD Cited As Infusion Pump EMR Integration Leader In KLAS Report
08/04/2016
BD Announces Results For 2016 Third Fiscal Quarter
07/28/2016
BD Names R. Andrew Eckert To Board Of Directors
07/26/2016
BD Board Declares Dividend
07/19/2016
BD Hits Century Mark With Infusion Pump Interoperability
07/01/2016
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
06/16/2016
BD and Check-Points Announce Development and Global Distribution Agreement for BD MAX™ Assays that Detect Carbapenem-resistant Organisms
06/03/2016
BD to Present at Investor Healthcare Conferences
05/26/2016
BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody™ System
05/24/2016
BD Board Declares Dividend
05/13/2016
BD Expands Reproductive and Sexually Transmitted Infections Portfolio with CE Mark for the BD MAX™ Vaginal Panel
05/05/2016
BD Announces Results For 2016 Second Fiscal Quarter
05/04/2016
BD to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
04/22/2016
BD Introduces New Low-Temperature Sterilization Containers
04/21/2016
BD Divests Vertebral Augmentation Solutions Business to Stryker
04/01/2016
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
03/15/2016
MedMined® Surveillance Advisor Wins 2015/2016 KLAS Category Leader Award
03/08/2016
BD, Apax Partners to Form Joint Venture for Respiratory Solutions
03/07/2016
BD Receives FDA Approval for New Automated Cervical Cancer Screening System
02/24/2016
Alaris® System Named 2015 Best In KLAS for Smart Pumps
02/22/2016
BD to Present at Investor Healthcare Conferences
02/17/2016
BD Receives FDA 510(k) Clearance for New Blood Collection Device to Help Enhance Patient and Clinician Experience
02/12/2016
BD Unveils New Next Generation Sequencing Library Prep System at the 2016 Advances in Genome Biology and Technology Meeting
02/10/2016
BD Receives FDA 510(k) Clearance for Diagnostic Device for HIV/AIDS
02/08/2016
BD Launches BD FACSymphony™ High-Speed Cell Analyzer to Enable Identification and Analysis of Rare Cell Types
02/03/2016
BD Announces Results For 2016 First Fiscal Quarter
01/25/2016
BD Board Declares Dividend
01/15/2016
BD Announces Webcast of Annual Meeting of Shareholders
01/08/2016
BD Divests BD Rx Business, Adding IV Solutions
01/07/2016
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
01/04/2016
BD to Present at the 34th Annual J. P. Morgan Healthcare Conference
12/12/2015
BD Unveils New BD FACSCelesta™ Flow Cytometer During the 2015 American Society for Cell Biology Annual Meeting
12/07/2015
BD Introduces Simplified Comprehensive IV Management
12/02/2015
BD Showcases Expanded Portfolio to Support Enterprise Medication Management at the ASHP 2015 Midyear Meeting
11/23/2015
BD Board Declares Dividend
11/12/2015
BD to Present at the Stifel 2015 Healthcare Conference
11/04/2015
BD Announces Results For 2015 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2016 Guidance
10/06/2015
BD Launches the BD FACSseq™ Cell Sorter with BD™ Precise Assays for High Precision Single Cell Genomics
10/05/2015
BD Celebrates National Health Information Technology (NHIT) Week
09/30/2015
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
09/24/2015
BD MAX™ Enteric Parasite Panel Receives FDA Clearance for Detection of Common and Pathogenic Intestinal Parasites
09/11/2015
BD to Present at the Morgan Stanley Global Healthcare Conference 2015
08/25/2015
BD to Acquire Cellular Research to Develop a Leading Genomics Platform for Single Cell Analysis
08/06/2015
BD Announces Results for 2015 Third Fiscal Quarter and Raises EPS Guidance for Fiscal 2015
07/28/2015
BD Board Declares Dividend
07/15/2015
BD Opens Advance Diabetes Care Headquarters in Andover, Mass.
07/13/2015
BD Announces Sustainability Goals for 2020
07/01/2015
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
06/27/2015
New Study Shows Higher Rates of C. difficile Infection in Hospitals that Use Reusable Sharps Containers
06/08/2015
BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart™ Technology Designed to Improve Insulin Pump Therapy
06/06/2015
New Clinical Data Suggest Infusion Set with BD FlowSmart™ Technology May Improve Insulin Flow and Reduce Silent Occlusions
06/02/2015
BD Participates in White House Forum on Antibiotic Stewardship
05/29/2015
BD to Present at Investor Healthcare Conferences
05/19/2015
BD Board Declares Dividend
05/13/2015
BD Receives FDA Clearance for a Novel Infusion Set with BD FlowSmart™ Technology to Enhance the Use of Insulin Pumps
05/07/2015
BD Announces Results For 2015 Second Fiscal Quarter
05/04/2015
BD to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference
04/23/2015
Becton, Dickinson and Company Announces Final Results of Exchange Offers
04/22/2015
BD "Dynamic Duos" Education Campaign Aims to Help People Simplify Life with Diabetes
04/09/2015
Becton, Dickinson and Company Announces Results of Early Tenders and Consents in Exchange Offers
04/06/2015
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
03/26/2015
Becton, Dickinson and Company to Commence Exchange Offers
03/17/2015
Becton Dickinson Completes Acquisition Of CareFusion
03/13/2015
European Commission Clears BD Acquisition Of CareFusion
03/03/2015
BD to Present at the Barclays Global Healthcare Conference
03/02/2015
BD Acquires CRISI Medical Systems
02/26/2015
BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing
02/05/2015
BD Announces Results For 2015 First Fiscal Quarter
01/27/2015
BD Board Declares Dividend
01/21/2015
CareFusion Stockholders Approve Proposed Merger With Becton, Dickinson
01/16/2015
BD Announces Webcast of Annual Meeting of Shareholders
01/08/2015
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
01/07/2015
The BD™ Intelliport® Medication Management System Receives Clearance from the Food and Drug Administration (FDA)
01/07/2015
BD to Present at the 33rd Annual J. P. Morgan Healthcare Conference
12/08/2014
BD to Present Total Hospital Pharmacy Solutions at the 2014 American Society of Health-System Pharmacists Midyear Clinical Meeting
12/08/2014
Becton Dickinson and CareFusion Announce Date of Special Meeting in Proposed Merger
12/05/2014
Aethon and BD Announce Collaboration to Develop Integrated Medication Management Solution
12/04/2014
Becton, Dickinson and Company to Offer Senior Unsecured Notes
11/25/2014
BD to Present at the 26th Annual Piper Jaffray Healthcare Conference
11/25/2014
BD Board Declares Dividend
11/20/2014
Becton Dickinson And CareFusion Announce Expiration Of HSR Act Waiting Period In Proposed Transaction
11/11/2014
BD to Present at the Stifel 2014 Healthcare Conference
11/04/2014
BD Announces Results For 2014 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2015 Guidance
10/13/2014
BD Acquires GenCell Biosystems
10/05/2014
BD To Acquire CareFusion For $12.2 Billion
10/01/2014
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
09/23/2014
World Health Organization Issues Prequalification of BD FACSPresto™ Near-Patient CD4 Counter System for HIV/AIDS Monitoring
09/04/2014
BD to Present at the Morgan Stanley Global Healthcare Conference
08/25/2014
BD - Together with Direct Relief and the National Association of Community Health Centers - Announce Winners of the 2014 BD Helping Build Healthy Communities(SM) Innovations in Care Awards
08/06/2014
BD AutoShield™ Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
08/04/2014
BD Expands its Suite of Open System Solutions on the Fully Automated BD MAX™ Platform
07/31/2014
BD Announces Results For 2014 Third Fiscal Quarter
07/28/2014
New Chlamydia and Gonorrhea Assays on the BD Viper™ LT System Receive FDA 510k Clearance
07/22/2014
BD Board Declares Dividend
06/30/2014
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
06/30/2014
BD Applauds High-level Events to Reduce Preventable Maternal, Newborn and Child Deaths
06/17/2014
BD Signs Agreement for Installation of the BD Cato™ Workflow Solution in Leading Cancer Center
06/11/2014
Low-Volume Clinical Laboratories Now Have Access to Advanced Data Management with New Blood Culture Instrument Connectivity
06/05/2014
BD Issues 2013 Sustainability Report
05/29/2014
BD to Present at Investor Healthcare Conferences
05/20/2014
BD Board Declares Dividend
05/20/2014
Royal Jubilee Hospital, Victoria, Vancouver Island, to Be the First Canadian Hospital to Install the BD Kiestra™ TLA Fully Automated Microbiology Lab System
05/07/2014
The BD MAX™ Enteric Bacterial Panel Receives FDA Clearance to Detect the Most Common Causes of Bacterial Gastroenteritis
05/02/2014
BD to Present at the Deutsche Bank 39th Annual Health Care Conference
05/01/2014
BD Announces Results For 2014 Second Fiscal Quarter
04/24/2014
BD Launches New Point-of-Care System for HIV/AIDS Patients
04/03/2014
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
03/24/2014
Dr. Claire Pomeroy Elected as BD Director
03/19/2014
New RSV Test Provides Healthcare Providers Objective Results in Minutes
02/25/2014
BD to Present at Investor Healthcare Conferences
02/25/2014
Healthcare Providers Can Diagnose Group A Strep in Minutes with New Test
02/07/2014
BD to Present at Investor Healthcare Conferences
02/07/2014
Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development
02/04/2014
BD Announces Results For 2014 First Fiscal Quarter
01/28/2014
BD Board Declares Dividend
01/14/2014
BD Announces Webcast of Annual Meeting of Shareholders
01/13/2014
New Laboratory Test Helps Hospitals Detect Newly Emerging Strains of Drug-Resistant Superbug
01/07/2014
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
01/07/2014
BD Acquires Alverix, Inc.
01/03/2014
BD to Present at Investor Healthcare Conferences
12/03/2013
Novel Molecular Assay for Patient Screening Detects S. aureus and Newly Emerging MRSA Strains Available in the United States
11/27/2013
BD to Present at the 25th Annual Piper Jaffray Healthcare Conference
11/26/2013
BD Board Increases Dividend
11/19/2013
Rapid Delivery Program Product Portfolio Expands to Biopharmaceutical Injectable Market
11/13/2013
BD Joins National Patient Safety Foundation Corporate Council, Furthers Commitment to Safety
11/06/2013
BD Diagnostics Presents Integrated Cervical Cancer Testing Solutions at EUROGIN 2013
11/05/2013
BD Announces Results for 2013 Fourth Fiscal Quarter and Full Year; Provides Fiscal 2014 Guidance
11/04/2013
BD Rx Announces FDA Approval of High-Demand Injectable for Pain Management
10/28/2013
BD Launches BD Helping Build Healthy Communities with Direct Relief and the National Association of Community Health Centers
10/16/2013
Sartorius Stedim Biotech and BD Diagnostics Strengthen Cooperation in the Area of Microbiological Diagnostics
09/27/2013
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
09/27/2013
World Health Organization and BD Announce New Commitment to Address Maternal and Newborn Mortality
09/20/2013
Jury Returns Verdict in RTI vs. BD Lawsuit
09/05/2013
New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research
08/30/2013
BD to Present at Investor Healthcare Conferences
08/29/2013
FDA Approves Third Drug in BD Simplist™ Prefilled Injectable Line of Products
08/27/2013
BD ProbeTec™ Trichomonas vaginalis Q(x) Assay Launches on the BD Viper™ System with XTR™ Technology in the United States
08/26/2013
BD Supports the FDA's Proposal to Reclassify Rapid Influenza Tests
08/13/2013
New Syringe Designed to Position More Large Volume Injectable Drugs for Prefill Administration
08/01/2013
BD Announces Results For 2013 Third Fiscal Quarter
07/30/2013
BD and the College of American Pathologists Announce Strategic Alliance to Support Laboratory Quality and Performance in India and China
07/23/2013
BD Board Declares Dividend
07/08/2013
BD Appoints Christopher Reidy as Chief Financial Officer
07/03/2013
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
06/21/2013
BD's Latest Pen Needle Innovation Designed to Make Injections Easier for People with Diabetes
06/19/2013
New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research
06/18/2013
JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes
06/06/2013
BD to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
06/04/2013
BD and Heart to Heart International Continue Ongoing Collaboration to Help Improve Healthcare in Haiti with Third Volunteer Service Trip
06/03/2013
New Prefillable Syringe System Offers Advanced Glass Technology for Biopharmaceutical Injectable Drug Delivery
05/24/2013
BD to Present at the Deutsche Bank 38th Annual Health Care Conference
05/22/2013
BD Issues 2012 Sustainability Report
05/21/2013
BD Board Declares Dividend
05/02/2013
BD Announces Results For 2013 Second Fiscal Quarter
04/23/2013
FDA Approves Second Drug in BD Simplist™ Prefilled Injectable Line of Products
04/17/2013
Nearly 8 Million Healthcare Personnel Come in Contact with Chemotherapy Drugs, According to CDC
04/11/2013
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS™ Passive Needle Guard
04/09/2013
New Molecular Assay Provides Healthcare Facilities with a Simple, Efficient Way to Detect Dangerous Superbug
04/08/2013
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
04/08/2013
CML HealthCare Inc. to Install North America's First and World's Largest Fully Automated BD Kiestra™ Microbiology Platform
03/27/2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
03/13/2013
BD Announces Appointment of Dr. Ellen Strahlman as Chief Medical Officer and Senior Vice President, Research & Development
03/12/2013
BD Acquires Cato Software Solutions
02/28/2013
BD to Present at Investor Healthcare Conferences
02/28/2013
Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
02/07/2013
BD to Present at Investor Healthcare Conferences
02/05/2013
BD Announces Results for 2013 First Fiscal Quarter
01/29/2013
BD Board Declares Dividend
01/29/2013
Catherine M. Burzik Elected as BD Director
01/23/2013
BD Announces Webcast of Annual Meeting of Shareholders
01/15/2013
BD PhaSeal™ System Receives Clearance from FDA Under Newly Created ONB Product Code
01/08/2013
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
12/26/2012
BD Completes Acquisition of Safety Syringes, Inc.
12/21/2012
BD to Present at Investor Healthcare Conferences
12/10/2012
Medication Errors from Injectable Drugs Harm One Million Inpatients Each Year Adding Billions in Cost, New Study Finds
11/21/2012
BD to Present at the 24th Annual Piper Jaffray Healthcare Conference
11/20/2012
BD Board Increases Dividend by 10 Percent
11/07/2012
BD Announces Results For 2012 Fourth Fiscal Quarter And Full Year
11/06/2012
BD Announces Funding and Product Support for Hurricane Sandy Relief Efforts
11/06/2012
BD Announces Appointment of William A. Kozy as Chief Operating Officer
11/01/2012
BD Completes Sale of Majority of Discovery Labware Unit
10/29/2012
BD is Awarded WindMade(TM) Certification; Ranks Among Top 40 U.S. Companies in Newsweek's 2012 Green Rankings
10/29/2012
BD is Awarded WindMade™ Certification; Ranks Among Top 40 U.S. Companies in Newsweek's 2012 Green Rankings
10/15/2012
BD and Lab21 Collaborate to Develop New Oncology Assays on the BD MAX™ Platform
10/11/2012
New Disposable Pen Injector Offers Ease of Use as well as Customization Options for Use with a Wide Range of Injectable Drugs
10/10/2012
BD Announces Chief Financial Officer Transition
10/03/2012
New RSV Test Provides Reliable Results in Minutes
10/02/2012
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
09/27/2012
New Molecular Assay Detects Rapidly Emerging Multidrug-Resistant Superbug
09/20/2012
New Influenza Test Offers Labs Advanced Performance and Reliable Results
09/19/2012
BD Introduces Advanced Needle Technology Designed to Enhance Patient Comfort and Improve Patient Adherence in Diabetes Care
08/27/2012
BD Acquires Sirigen Group Limited
08/14/2012
New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
08/02/2012
BD Announces Results For 2012 Third Fiscal Quarter
07/26/2012
BD and PEPFAR Launch Labs for Life to Strengthen Laboratories in Regions Heavily Burdened by Disease
07/24/2012
BD Board Declares Dividend
07/23/2012
BD Board of Directors Elects Rebecca W. Rimel
07/11/2012
BD Announces Agreement to Acquire Safety Syringes, Inc.
07/09/2012
New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug
06/28/2012
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
06/23/2012
New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of Life Science Applications
05/30/2012
BD to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
05/23/2012
BD Issues 2011 Sustainability Report
05/22/2012
BD Appoints CEO Vincent A. Forlenza as Chairman of the Board
05/22/2012
BD Board Declares Dividend
05/21/2012
BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti
05/02/2012
BD to Present at Investor Healthcare Conferences
05/01/2012
BD Announces Results for 2012 Second Fiscal Quarter
04/19/2012
Protecting Healthcare Workers from Exposure to Hazardous Drugs
04/10/2012
BD Signs Agreement to Sell Majority of Discovery Labware Unit
04/02/2012
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
03/28/2012
New IVD Product is Designed to Improve Prevention and Control of GBS in Newborns
03/27/2012
New Collaboration Aims to Improve Access to TB Diagnostics
03/09/2012
BD to Present at the Barclays Capital Global Healthcare Conference
02/14/2012
First Specimen Collection Training Curriculum in Sub-Saharan Africa Launches at Kenyan Medical Training College
02/13/2012
BD Acquires KIESTRA Lab Automation BV
02/10/2012
BD to Present at Investor Healthcare Conferences
02/08/2012
Mesenchymal Stem Cells Have New Cell Culture Environment
02/07/2012
BD Announces Results for 2012 First Fiscal Quarter
01/31/2012
BD Board Declares Dividend
01/24/2012
BD Announces Webcast of Annual Meeting of Shareholders
01/11/2012
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
01/04/2012
BD to Present at the 30th Annual J. P. Morgan Healthcare Conference
12/19/2011
New BD Veritor(TM) System for Rapid Detection of Flu A+B Receives 510(k) Clearance and CLIA Waiver
12/19/2011
New BD Veritor™ System for Rapid Detection of Flu A+B Receives 510(k) Clearance and CLIA Waiver
11/22/2011
BD to Present at the 23rd Annual Piper Jaffray Healthcare Conference
11/22/2011
BD Board Increases Dividend
11/02/2011
BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year
10/28/2011
BD Announces 2011 Analyst Day and Webcast
10/04/2011
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
09/21/2011
BD Launches a New Generation Short Peripheral IV Catheter to Reduce Risk of Blood Exposure to Healthcare Workers
09/13/2011
BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®
09/07/2011
BD to Present at the 2011 Morgan Stanley Global Healthcare Conference
08/16/2011
BD Completes Acquisition of Carmel Pharma
08/03/2011
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX(TM) Molecular Testing System
08/02/2011
BD Announces Results For 2011 Third Fiscal Quarter
07/27/2011
BD Announces Agreement to Acquire Carmel Pharma, Inc.
07/26/2011
BD Board of Directors Elects Vincent A. Forlenza as Next Chief Executive Officer, Effective October 1, 2011
07/26/2011
BD Board Declares Dividend
07/08/2011
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
06/09/2011
BD and Heart to Heart International Launch Volunteer Service Trip to Help "Build Back Better" in Haiti
06/03/2011
BD to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
05/24/2011
BD Board Declares Dividend
05/20/2011
BD Biosciences Launches New Cell Analyzer to Streamline Research Workflow
05/19/2011
BD Launches BD MAX(TM) System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases
05/19/2011
BD Issues 2010 Sustainability Report
05/09/2011
BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX(TM) System
04/28/2011
BD to Present at Investor Healthcare Conferences
04/26/2011
BD Announces Results for 2011 Second Fiscal Quarter
04/13/2011
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
04/13/2011
BD and Waste Management Launch Initiative to Recycle Medical Sharps
03/18/2011
BD Completes Acquisition of Accuri Cytometers, Inc.
03/15/2011
BD Donates $325,000 for Japan Earthquake and Tsunami Relief Efforts
03/15/2011
BD Statement Regarding Impact of Japan Earthquake
02/25/2011
BD to Present at Investor Healthcare Conferences
02/07/2011
BD Announces Agreement to Acquire Accuri Cytometers, Inc.
02/07/2011
BD Announces Results For 2011 First Fiscal Quarter
02/01/2011
BD Announces Results of Shareholder Votes at Annual Meeting
02/01/2011
BD Board Declares Dividend
01/24/2011
BD and Rady Children's Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal
01/11/2011
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
01/05/2011
BD Announces Webcast of Annual Meeting of Shareholders
01/04/2011
BD to Present at the 29th Annual J. P. Morgan Healthcare Conference
01/03/2011
New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients
11/24/2010
BD to Present at the 22nd Annual Piper Jaffray Health Care Conference
11/23/2010
BD Board Increases Dividend
11/16/2010
BD Taps Leading Voice in Infection Prevention Community to Advance Efforts to Reduce Healthcare-Associated Infections
11/03/2010
BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year
10/25/2010
BD Ranks Among Top 25 U.S. Companies in Newsweek's 2010 Green Rankings; Receives EPA Green Power Leadership Award; Named to Dow Jones Sustainability World Index for Fifth Consecutive Year
10/14/2010
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
09/08/2010
BD to Present at the 2010 Morgan Stanley Global Healthcare Conference
08/03/2010
BD Receives CLIA 'Moderate Complexity' Status for the BD MAX(TM) GBS Assay
08/02/2010
BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform
07/29/2010
BD Announces Appointment of Zachary A. Nagle as Vice President, Investor Relations
07/29/2010
BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer
07/29/2010
BD Announces Results for Third Quarter Fiscal 2010
07/27/2010
BD Board Declares Dividend
07/26/2010
BD Board of Directors Elects Christopher Jones
07/07/2010
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
06/09/2010
BD to Present at Goldman Sachs 31st Annual Global Healthcare Conference
06/08/2010
BD Signs Agreements to Sell Ophthalmic Systems Unit, Other Platforms
06/07/2010
BD Launches World's Smallest Pen Needle
06/03/2010
BD Issues 2009 Sustainability Report
06/02/2010
BD Announces First FDA-Cleared Assay on the BD MAX(TM) System to Detect Group B Streptococcus
05/25/2010
BD Board Declares Dividend
05/05/2010
BD to Present at Investor Healthcare Conferences
04/29/2010
BD Announces Results for Second Quarter Fiscal 2010
04/08/2010
BD Announces Live Webcast of Second Quarter Fiscal 2010 Earnings Conference Call
03/15/2010
BD to Present at Barclays Capital 2010 Healthcare Conference
03/05/2010
BD Named Industry Champion on FORTUNE's List of the 'World's Most Admired Companies'
02/23/2010
BD Biosciences Launches BD FACSAria(TM) III Flow Cytometry System
02/08/2010
BD Announces Worldwide Voluntary Recall of BD Q-Syte(TM) Luer Access Devices and BD Nexiva(TM) Closed IV Catheter Systems
02/03/2010
BD Launches 'Be a Flu Fighter' Campaign to Promote Influenza Awareness and Prevention in Schools, Hospitals and Laboratories
02/02/2010
BD Announces Results of Shareholder Votes at Annual Meeting
02/02/2010
BD Board Declares Dividend
01/28/2010
BD Announces Results for First Fiscal Quarter
01/27/2010
BD Increases Haiti Relief Fund to Include $5 Million in Product Donations
01/15/2010
BD Establishes $1.2 Million Fund for Haiti Earthquake Relief Efforts
01/14/2010
BD Announces Webcast of Annual Meeting of Shareholders
01/11/2010
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
01/08/2010
BD Applauds PEPFAR's Broadened Emphasis on Strengthening Health Systems
12/29/2009
BD to Present at Investor Healthcare Conferences
11/24/2009
BD Board Increases Dividend and Authorizes Additional Share Repurchases
11/20/2009
BD Completes Acquisition of HandyLab, Inc.
11/04/2009
BD to Present at Investor Healthcare Conferences
11/04/2009
BD Announces Results for Fourth Fiscal Quarter and Full Year
10/23/2009
BD Announces Agreement to Acquire HandyLab, Inc.
10/07/2009
BD Ranked in the Top 100 Greenest Big Companies by Newsweek; Named Again to Dow Jones Sustainability World and North America Indexes
10/06/2009
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
09/03/2009
BD Announces Flu Product Order from U.S. Government
09/01/2009
BD to Present at Investor Healthcare Conferences
08/11/2009
BD and PEPFAR Collaboration Will Improve Blood-Drawing Practices in Hospitals and Clinics in Sub-Saharan Africa
08/06/2009
BD Adds Surveillance Capability to Infectious Disease Portfolio
07/30/2009
BD Announces Results for Third Fiscal Quarter
07/28/2009
BD Board Declares Dividend
07/19/2009
BD/PEPFAR Lab-Strengthening Initiative Marks Progress in Fight Against HIV/AIDS and TB in Sub-Saharan Africa
06/29/2009
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
06/17/2009
BD and FIND Achieve Milestone in Global Battle Against MDR-TB
06/01/2009
BD to Present at Investor Healthcare Conferences
05/20/2009
BD Board Declares Dividend
05/18/2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
05/08/2009
BD Extends Decade-Long Support for UNICEF's Campaign to Eliminate Maternal and Neonatal Tetanus
05/04/2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
05/01/2009
BD to Present at Investor Healthcare Conferences
04/28/2009
BD Announces Results for Second Fiscal Quarter
04/01/2009
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
03/11/2009
BD Named to 100 Best Corporate Citizens List by CRO Magazine
03/05/2009
BD to Present at the Cowen and Company 29th Annual Healthcare Conference
02/23/2009
BD Ranks 23rd on EPA's Fortune 500 List of Green Power Purchasers
02/03/2009
BD Announces Results of Shareholder Votes at Annual Meeting
02/03/2009
BD Board Declares Dividend
01/28/2009
BD Announces Results for First Fiscal Quarter
01/14/2009
BD Announces Webcast of Annual Meeting of Shareholders
01/14/2009
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
01/12/2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
12/24/2008
BD to Present at Investor Healthcare Conferences
12/04/2008
BD Receives FDA Approval for the BD FocalPoint(TM) GS Imaging System to Enhance the Detection of Cervical Cancer
11/25/2008
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
11/05/2008
BD Announces Executive Appointments of President and Chief Financial Officer
11/05/2008
BD Announces Results for Fourth Fiscal Quarter and Full Year
11/03/2008
BD to Present at Investor Healthcare Conferences
10/02/2008
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
09/25/2008
Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital
08/27/2008
BD to Present at Investor Healthcare Conferences
07/24/2008
BD Announces Results for Third Fiscal Quarter
07/22/2008
BD Board Declares Dividend
07/07/2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
06/24/2008
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
06/03/2008
BD to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
05/20/2008
BD Board Declares Dividend
05/13/2008
BD Announces Acquisition of Cytopeia
05/07/2008
BD to Present at Investor Healthcare Conferences
04/23/2008
BD to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference
04/23/2008
BD Announces Results for Second Fiscal Quarter
03/27/2008
BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana
03/26/2008
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
03/26/2008
BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference
03/18/2008
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
03/17/2008
BD GeneOhm(TM) MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates
03/07/2008
BD to Present at Investor Healthcare Conferences
01/29/2008
BD Announces Results of Shareholder Votes at Annual Meeting
01/29/2008
BD Board Declares Dividend
01/28/2008
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
01/24/2008
BD Announces Results For First Fiscal Quarter
01/16/2008
BD Announces Webcast of Annual Meeting of Shareholders
01/04/2008
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
01/02/2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
12/27/2007
BD to Present at the 26th Annual JPMorgan Healthcare Conference
11/20/2007
BD Board Declares Dividend
11/07/2007
BD to Present at Investor Healthcare Conferences
11/05/2007
BD and FIND Help Address Emergence of XDR-TB With New Pricing Agreement for Liquid Culture System
11/02/2007
BD Board of Directors Elects Cathy E. Minehan
11/01/2007
BD Announces Results for Fourth Fiscal Quarter and Full Year
10/31/2007
BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
10/01/2007
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
09/11/2007
BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
08/30/2007
BD to Present at the Bear Stearns 20th Annual Healthcare Conference
08/24/2007
BD to Present at the Thomas Weisel Partners Healthcare Conference 2007
08/07/2007
BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology Officer
07/26/2007
BD Announces Results for Third Fiscal Quarter
07/24/2007
BD Board Declares Dividend and Authorizes Additional Share Repurchases
07/24/2007
BD Board of Directors Elects Marshall O. Larsen
06/29/2007
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
06/04/2007
BD to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference
05/22/2007
BD Board Declares Dividend
05/18/2007
BD to Present at the Bank of America 2007 Healthcare Conference
05/17/2007
BD to Present at the Sanford C. Bernstein & Co., LLC Twenty-Third Annual Strategic Decisions Conference
04/26/2007
Variant Strain of Chlamydia May Go Undetected
04/25/2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures
04/25/2007
BD Discloses Notice of Arbitration and Dispute Resolution Proceedings
04/25/2007
BD Announces Results for Second Fiscal Quarter
04/18/2007
BD to Present at the 2007 Morgan Stanley Global Healthcare Unplugged Conference
03/26/2007
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
03/26/2007
BD and Direct Relief International Launch Volunteer Service Program to Improve Healthcare in Ghana
03/22/2007
BD and FIND Announce Expanded Collaboration to Improve Tuberculosis Diagnostics Worldwide
03/09/2007
BD Honored as One of 'America's Most Admired Companies' in FORTUNE Magazine's Annual Rankings
03/01/2007
BD to Present at the Cowen and Company 27th Annual Healthcare Conference
02/26/2007
BD Biosciences and Roche Collaborate to Advance the Study of Cell Signal Transduction through New Phosphorylation Site Antibody Targets and Applications
01/30/2007
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
01/30/2007
BD Announces Results of Shareholder Votes at Annual Meeting
01/30/2007
BD Board Declares Dividend
01/25/2007
BD Announces Results for First Fiscal Quarter
01/10/2007
BD Announces Webcast of Annual Meeting of Shareholders
12/28/2006
BD to Present at the 25th Annual JPMorgan Healthcare Conference
12/21/2006
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
12/20/2006
BD Completes Acquisition of TriPath Imaging
11/30/2006
BD and International Council of Nurses Collaborate to Address the Health Human Resource Crisis in Africa
11/21/2006
BD Board Declares Dividend
11/20/2006
BD to Present at the Lazard Capital Markets Third Annual Life Sciences Conference
11/09/2006
BD to Present at the 2006 Credit Suisse Healthcare Conference
11/06/2006
BD to Present at the ArgusVision 2007: Eyes on the Future Conference
11/02/2006
BD Announces Results for Fourth Fiscal Quarter and Full Year
11/01/2006
BD to Present at the CIBC World Markets Seventeenth Annual Healthcare Conference
10/19/2006
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
09/28/2006
BD Announces Plan to Exit Blood Glucose Monitoring Market
09/26/2006
BD Board of Directors Elects Dr. Claire M. Fraser-Liggett
09/18/2006
BD Biosciences Releases BD FACSCanto(TM) II Flow Cytometry System for In Vitro Diagnostics Use
09/08/2006
BD to Acquire TriPath Imaging, Inc.
09/05/2006
BD to Present at the Bear Stearns 19th Annual Healthcare Conference
08/31/2006
BD to Present at the Thomas Weisel Partners Healthcare Conference 2006
08/14/2006
BD Makes Filing to Report Bid to Acquire TriPath Imaging, Inc.
08/12/2006
BD Diagnostics Announces Availability in Africa of New CD4 Stabilization Blood Collection Technology
07/28/2006
BD Announces Results for Third Fiscal Quarter
07/25/2006
BD Board of Directors Elects Dr. Adel A.F. Mahmoud
07/25/2006
BD Board Declares Dividend
07/17/2006
BD Medical Announces Positive Results for New York City BD Diabetes Makeover(SM) Program
07/06/2006
BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper(TM) Robotic Instrumentation and Molecular Testing of Sexually Transmitted Infections
06/15/2006
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
06/12/2006
BD and Catholic Medical Mission Board Partner to Bolster Zambian Healthcare Clinics' HIV/AIDS Efforts
06/06/2006
BD to Present at the Goldman Sachs 27th Annual Global Healthcare Conference
05/23/2006
BD Board Declares Dividend
05/10/2006
BD to Present at the Bank of America Healthcare Conference 2006
04/26/2006
BD Announces Results for Second Fiscal Quarter
04/24/2006
BD to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2006
03/27/2006
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
03/20/2006
BD Medical to Support Gary Hall, Jr. Through 2008 Olympic Games
03/01/2006
BD to Present at the SG Cowen & Co. 26th Annual Health Care Conference
02/23/2006
BD Diagnostics Announces Multi-Year Agreement With Quest Diagnostics for BD Viper(TM) System
02/14/2006
BD Completes Acquisition of GeneOhm Sciences, Inc.
02/02/2006
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
01/31/2006
BD Board Declares Dividend
01/26/2006
BD Announces Results For First Fiscal Quarter
01/24/2006
BD Announces Webcast of Annual Meeting of Shareholders
01/10/2006
BD Announces Agreement to Acquire GeneOhm Sciences, Inc.
01/09/2006
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
01/09/2006
BD Diagnostics Announces FDA 510(k) Clearance of the BD Viper(TM) System
12/28/2005
BD to Present at the 24th Annual JPMorgan Healthcare Conference
12/21/2005
BD Micro-Delivery System Licensed by Sanofi Pasteur
12/20/2005
BD to Allow Poison Pill to Expire; Also Adopts New Policy Regarding Election of Directors
11/22/2005
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
11/07/2005
BD to Present at the 2005 Credit Suisse First Boston Health Care Conference
11/03/2005
BD Announces Results for Fourth Fiscal Quarter and Full Year
11/02/2005
BD to Present at CIBC World Markets Healthcare Conference
11/02/2005
American Red Cross and BD Announce Expanded Collaboration to Support Measles Initiative
10/19/2005
BD Diagnostics Announces FDA 510(k) Clearance for BD ProbeTec(TM) Urine Preservative Transport (UPT)
09/27/2005
BD Diagnostics Announces FDA 510(k) Clearance of BD Directigen(TM) EZ Flu A+B Test
09/22/2005
BD Announces Preparation Efforts Ahead of Hurricane Rita
09/20/2005
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
09/01/2005
BD Donates $500,000 to Hurricane Katrina Disaster Relief Efforts
09/01/2005
BD to Present at Bear Stearns 18th Annual Healthcare Conference
08/30/2005
BD to Present at Thomas Weisel Partners Healthcare Tailwinds Conference
08/12/2005
BD Diabetes Care Announces Successful Results of DC Diabetes Makeover Initiative
07/26/2005
BD Board Declares Dividend
07/22/2005
BD Announces Results for Third Fiscal Quarter
07/01/2005
BD Announces Agreement to Sell Clontech
06/09/2005
BD to Present at Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference
05/24/2005
BD Board Declares Dividend
05/18/2005
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
05/18/2005
PreAnalytiX PAXgene(TM) Blood RNA System is Industry's First to Receive 510(K) Clearance From FDA and to Attain CE Mark
05/09/2005
BD to Present at Banc of America Securities Health Care Conference 2005
05/05/2005
BD and CMMB Join Forces to Address the Challenge of HIV/AIDS Pandemic in Zambia
05/04/2005
BD to Present at R. W. Baird 2005 Growth Stock Conference
05/03/2005
BD Announces Acquisition of Protein Separation Technology From FFE Weber GmbH
04/28/2005
BD to Present at Morgan Stanley Third Annual Global Healthcare Conference
04/27/2005
Webcast Alert: BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
04/27/2005
BD Announces Results for Second Fiscal Quarter
03/24/2005
Webcast Alert: BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
03/10/2005
BD to Present at SG Cowen 25th Annual Health Care Conference
02/23/2005
BD Named One of America's Most Admired Companies in FORTUNE Magazine's Annual Survey
02/02/2005
BD to Present at Merrill Lynch 2005 Global Pharmaceutical, Biotechnology & Medical Device Conference
02/01/2005
BD Board Declares Dividend
01/26/2005
BD Announces Webcast of Annual Meeting of Shareholders
01/26/2005
BD Announces Results for Fiscal First Quarter
01/20/2005
BD to Present at 17th Annual Piper Jaffray Health Care Conference
01/13/2005
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
01/10/2005
BD Announces FDA 510(k) Clearance of Simplified Test for Detection of Methicillin-Resistant Staphylococcus Aureus (MRSA)
01/05/2005
BD to Present at 23rd Annual JPMorgan Healthcare Conference
01/04/2005
BD Announces Tsunami Relief Efforts
12/15/2004
FIND and BD Combine International Efforts to Improve Rapid Tuberculosis Diagnosis for HIV-positive Patients in Developing Countries
11/23/2004
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
11/23/2004
BD Board of Directors Elects Gary A. Mecklenburg
11/22/2004
BD Releases New Version of BD.id(TM) Patient Identification System for Specimen Management
11/11/2004
Meeting the Challenge of Influenza
11/09/2004
Cellomics and BD Sign License Agreement to Further Expand Availability of High Content Screening
11/05/2004
BD Presents Diabetes Makeover to Inspire Better Diabetes Care
11/04/2004
FDA Alternate Site Clearance Offers BD Blood Glucose Meter Users More Convenience
11/04/2004
BD Announces Fiscal Fourth Quarter and Full Year Results
10/26/2004
BD to Present at CIBC World Markets Healthcare Conference
10/14/2004
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
10/06/2004
BD Launches Dora the Explorer(TM) Digital Thermometer
10/04/2004
BD Announces Plan to Sell Clontech
09/21/2004
BD Biosciences Releases BD FACSCanto(TM) Flow Cytometry System for Clinical Diagnostics
09/16/2004
BD to Present at UBS Global Life Sciences Conference
09/07/2004
BD to Present at Bear Stearns 17th Annual Healthcare Conference
09/02/2004
BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2004 Conference
07/27/2004
BD Board Declares Dividend
07/27/2004
BD Biosciences Pharmingen Designated One of the Best Workplaces for Commuters(SM) by U.S. EPA and DOT
07/22/2004
BD Announces Results for Fiscal Third Quarter
07/12/2004
BD Highlights Social Responsibility in First Global Corporate Citizenship Report
07/08/2004
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
07/02/2004
BD Announces Settlement of Pending Lawsuit
07/01/2004
BD Announces Acquisition of Atto Bioscience, Inc.
06/28/2004
BD FACSArray(TM) Bioanalyzer is Honored With a 2004 Silver Industrial Design Excellence Award
06/14/2004
BD Names J. Peter Natale as Chief Information Officer
06/10/2004
BD Submits 510(k) Application to FDA for Alternate Site Testing
06/02/2004
BD to Present at Goldman Sachs Twenty Fifth Annual Global Healthcare Conference
05/25/2004
BD Board Declares Dividend
05/24/2004
BD Announces FDA 510(k) Clearance of Molecular Test for Legionella pneumophila
05/12/2004
BD to Present at Banc of America Securities 2004 Health Care Conference
05/11/2004
BD Biosciences Releases the BD FACSCanto(TM) Flow Cytometry System
05/04/2004
BD(TM) Sharps Disposal By Mail System Meets EPA Guidelines, Helps Protect Public Against Injury, Infection
04/30/2004
BD to Present at Morgan Stanley Second Annual Global Healthcare Unplugged Conference
04/22/2004
BD Announces Fiscal Second Quarter Results
04/08/2004
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
03/29/2004
Basil L. Anderson Elected to BD Board of Directors
02/26/2004
BD to Present at the SG Cowen 24th Annual Health Care Conference
01/29/2004
BD Initiates Voluntary Recall of Certain BD(TM) Test Strips
01/29/2004
BD Announces Fiscal First Quarter Revenue and Earnings Growth
01/28/2004
BD to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
01/27/2004
BD Board Authorizes Additional Share Repurchases
01/27/2004
BD Board Declares Dividend
01/13/2004
BD to Announce First Fiscal Quarter Results
12/29/2003
BD Names Jeffrey S. Sherman Vice President and General Counsel
12/02/2003
BD to Present at Merrill Lynch Medical Technology University Conference
11/24/2003
BD Board Declares Dividend Increase of 50%
11/06/2003
BD Announces Record Fiscal Fourth Quarter and Full Year Revenues
11/05/2003
BD to Present at Credit Suisse First Boston's Health Care Conference
11/05/2003
BD Applauds Senate Action to Prevent Unsafe Medical Practices That Can Cause HIV/AIDS Spread in Africa
11/04/2003
BD to Present at the CIBC World Markets Fourteenth Annual Healthcare Conference
10/31/2003
BD Introduces New BD Ultra-Fine(TM) II, Thinnest Insulin Syringe Needle Available in US
10/15/2003
BD to Announce Fourth Fiscal Quarter and Year-End Results
10/10/2003
BD's VaxiNet Platform to Boost U.S. Immunization Efforts
09/04/2003
BD to Present at the Bear Stearns 16th Annual Healthcare Conference
08/29/2003
BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 Conference
08/22/2003
BD Statement Regarding Voluntary National Recall of BD ProbeTec ET Instrument
07/30/2003
BD to Present at Adams, Harkness & Hill 23rd Annual Summer Seminar
07/24/2003
BD Announces Results for Fiscal Third Quarter
07/22/2003
BD Board Declares Dividend
06/30/2003
BD to Announce Third Fiscal Quarter Results
06/05/2003
BD to Present at Goldman Sachs Twenty Fourth Annual Global Healthcare Conference
05/20/2003
BD Board Declares Dividend
05/01/2003
BD to Present at the 2003 Deutsche Bank Securities Health Care Conference
04/25/2003
BD Announces Fiscal Second Quarter Results; Company Increases Earnings Guidance For Fiscal Year 2003
04/24/2003
BD to Present at Morgan Stanley 1st Annual Healthcare Unplugged Conference
04/22/2003
Edward F. DeGraan Elected to BD Board of Directors
04/16/2003
BD Announces Plans for Discontinuation of Conventional Needle Sales in the U.S. Across Many Product Categories
04/15/2003
BD CEO Edward J. Ludwig Selected to Serve on U.S.-Japan Private Sector/Government Commission
04/02/2003
BD to Announce Second Fiscal Quarter Results
03/20/2003
BD Biosciences Launches New Flow Cytometry Products Incorporating Alexa Fluor(R) Dyes from Molecular Probes
03/18/2003
BD to Present at the SG Cowen 23rd Annual Heath Care Conference
03/14/2003
BD Names Vincent A. Forlenza President of BD Biosciences
02/05/2003
BD Comments Further on West Pharmaceutical Services Plant Incident
02/03/2003
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
01/29/2003
BD Statement in Response to West Pharmaceutical Services Plant Incident
01/28/2003
BD Board Authorizes Additional Share Repurchases
01/28/2003
BD Board Declares Dividend
01/23/2003
BD Announces Results for Fiscal First Quarter
01/22/2003
BD to Present at the US Bancorp Piper Jaffray 15th Annual Health Care Conference
01/08/2003
BD Introduces New Systems to Make Diabetes Monitoring and Management Easier, Faster, and Less Painful
01/08/2003
BD Presents New Blood Glucose Monitoring Products and Announces Strategic Relationships with Medtronic MiniMed and Eli Lilly and Company
01/06/2003
BD to Announce First Fiscal Quarter Results
01/02/2003
BD to Present at the 21st Annual JP Morgan H&Q Healthcare Conference
12/23/2002
BD Files Patent Infringement Complaint Against Tyco Healthcare
12/10/2002
BD to Present New Blood Glucose Monitoring Products
12/05/2002
BD Biosciences Launches New Instrument Design in the BD FACSAria Cell Sorter
11/26/2002
BD Board Declares Increased Dividend
11/06/2002
BD Announces Record Fiscal Fourth Quarter and Full Year Revenues
11/05/2002
BD to Present at Credit Suisse First Boston Healthcare Conference
10/28/2002
BD Consumer Healthcare Introduces Shortest Insulin Pen Needle Ever in the United States
10/21/2002
BD to Announce Fourth Fiscal Quarter and Year-End Results
09/24/2002
Bertram L. Scott Elected to BD Board of Directors
09/23/2002
BD Bifurcated Needle Launched for Smallpox Vaccination Efforts; Specialized Needle is Manufactured for International Biodefense Programs
09/18/2002
BD to Present at Banc of America Securities 32nd Annual Investment Conference
09/16/2002
BD to Present at Bear Stearns 15th Annual Healthcare Conference
09/10/2002
Tranzyme Announces the Opening of New Research Facilities at BD Technologies Incubator in Research Triangle Park, NC
09/10/2002
Tranzyme and BD Technologies Agree On Terms For A Strategic Alliance
09/04/2002
OBIT/BD Director Albert J. Costello Dies at 66
08/02/2002
BD to Present at Adams, Harkness & Hill Summer Seminar
07/26/2002
U.S. Fund for UNICEF and BD Partner to Accelerate Elimination of Maternal & Neonatal Tetanus
07/24/2002
BD Announces Results for Fiscal Third Quarter
07/23/2002
BD Declares Dividend
07/19/2002
Statement from BD (Becton, Dickinson and Company) in response to The New York Times article
07/01/2002
BD to Announce Third Fiscal Quarter Results
06/13/2002
BD to Present at Thomas Weisel Partners Growth Forum 4.0
06/04/2002
BD to Present at Goldman Sachs 23rd Annual Global Healthcare Conference
05/21/2002
BD Declares Dividend
05/03/2002
Time Change for BD Presentation at Deutsche Bank Securities 27th Annual Healthcare Conference
05/01/2002
BD to Present at Deutsche Bank Securities 27th Annual Healthcare Conference
04/24/2002
BD Announces Record $1 Billion Second Quarter Revenues
04/16/2002
BD Biosciences and NuGenesis Technologies Announce Strategic Alliance to Provide Secure Scientific Data Management Solution that Supports Regulatory Requirements
04/02/2002
BD to Announce Second Fiscal Quarter Results
03/26/2002
BD to Present at Banc of America Securities Healthcare Conference
02/20/2002
BD to Present at Lehman Brothers' 5th Annual Global Healthcare Conference
02/14/2002
Edward J. Ludwig Becomes BD Chairman of the Board
01/29/2002
BD to Present at Merrill Lynch Healthcare Conference
01/29/2002
BD Biosciences Enters Into Collaboration With the Harvard Institute of Proteomics to Determine Human Gene Function
01/23/2002
BD Announces Results for Fiscal First Quarter
01/22/2002
BD Declares Dividend
01/04/2002
BD to Present at JP Morgan H&Q Healthcare Conference
01/03/2002
BD to Announce First Fiscal Quarter Results
11/27/2001
Edward J. Ludwig to Become BD Chairman of the Board Effective February 2002
11/27/2001
BD Declares Increased Dividend
11/08/2001
BD to Present at CSFB Health Care Conference
11/07/2001
BD Announces Record Fiscal Fourth Quarter Revenues
10/30/2001
BD to Announce Fourth Fiscal Quarter and Year-End Results
10/29/2001
BD to Present at CIBC World Markets Healthcare Conference
10/04/2001
BD to Present at UBS Warburg Global Life Sciences Conference
09/24/2001
BD To Participate in Bear Stearns Healthcare Virtual Conference
09/24/2001
BD Pledges $1,000,000 to Help Victims and Families; Launches Worldwide Employee Contributions Campaign
09/17/2001
BD Board Authorizes Additional Share Repurchases
09/06/2001
BD to Present at Bear Stearns Annual Healthcare Conference
09/04/2001
BD to Present at Banc of America Securities Investment Conference
07/30/2001
BD Biosciences To Collaborate With Zyomyx To Apply Antibody Expertise To High Density Protein Biochips
07/25/2001
BD To Present at Adams, Harkness & Hill Summer Seminar
07/24/2001
BD Declares Dividend
07/18/2001
BD Announces Results for Fiscal Third Quarter; Quarter And Full Year Outlook In Line With Expectations
07/18/2001
BD Announces Webcast of Q3 Conference Call Thursday, July 19, 2001, at 8:30 a.m. EDT
06/20/2001
BD Congratulates GlaxoSmithKline On Receiving FDA Approval to Market Prefilled Vaccine System; Pediatric Vaccines To Be Packaged with BD SafetyGlide Needles
06/13/2001
BD Biosciences and Dyax Corp. Announce Research Products and Proteomics Alliance
06/07/2001
BD To Present at Goldman Sachs Healthcare Conference
05/22/2001
BD Declares Dividend
05/01/2001
BD To Present at Deutsche Banc Alex. Brown 2001 Health Care Conference
04/18/2001
BD Announces Record Revenues for Fiscal Second Quarter; Company Reaffirms Outlook for Full Year
04/12/2001
BD Announces Webcast of Q2 Conference Call; Thursday, April 19, 2001, at 8:30 a.m. EDT
04/04/2001
BD Announces Plans to Introduce Passive, Shielded I.V. Catheter
03/22/2001
BD To Present at Banc of America Securities Healthcare Conference
02/22/2001
BD To Present At Lehman Brothers Healthcare Conference
02/01/2001
BD to Present At Merrill Lynch Global Pharmaceutical, Medical Device & Biotechnology Conference
01/23/2001
BD Declares Dividend
01/23/2001
BD Names Dean Paranicas Vice President, Investor Relations and Public Affairs
01/22/2001
BD to Present at U.S. Bancorp Piper Jaffray Health Care Conference
01/17/2001
BD Announces Results for Fiscal First Quarter
01/11/2001
BD Announces Webcast of Q1 Conference Call
12/20/2000
BD Signs Agreement to Acquire Gentest Corporation
11/28/2000
BD Announces Election of James Orr to Board of Directors
11/28/2000
BD Declares Increased Dividend
11/21/2000
Cellular Technology Analyzers and BD Biosciences Enter Into an Elispot Applications Co-Development And Distribution Agreement
11/13/2000
BD To Present At CSFB Annual Healthcare Conference
11/08/2000
BD Announces Record Revenues for Fiscal Fourth Quarter and Full Year; Results Consistent With Company's September 26, 2000 Announcement
11/02/2000
BD Presentation to Investment Community Notice of Live Web cast
09/26/2000
BD Announces Program to Reduce Costs, Improve Financial Performance and Support Major Product Initiatives
09/26/2000
BD Names Stephen Mock Vice President, Investor and Public Relations
08/18/2000
Letter to Analysts/Investors
07/25/2000
BD Declares Dividend
07/20/2000
BD Announces Results for Third Fiscal Quarter; Safety and Biosciences Sales Add to Top Line Growth
07/19/2000
BD Launches Safety Compliance Initiative for Needlestick Prevention
06/05/2000
BD Names Bridget Healy General Counsel
05/30/2000
BD Names John Considine Executive VP and Chief Financial Officer
05/23/2000
BD Declares Dividend
04/25/2000
Chlamydia and Gonorrhea Now Simple to Diagnose; US Health Organizations Call for More Aggressive Screening
04/19/2000
BD Provides Unrestricted Grant to Support Needle Safety Campaign
04/18/2000
BD Announces Strong Results for Second Fiscal Quarter and Confirms Outlook for Year
02/24/2000
Hospital Risk Managers Find Medication Error a Significant Problem; BD Survey Reveals Reporting Errors Not Rewarded
02/23/2000
BD Expects Rapid Resumption of Product Supply Following Voluntary Recall; Offers Alternate Product at No Charge in Interim and Confirms E.P.S. Expectations
01/25/2000
BD Declares Dividend
01/20/2000
BD Reports Results for Fiscal First Quarter; Revenues Increase 12 Percent
11/23/1999
BD Names Robert M. Hallenbeck VP and General Counsel
11/23/1999
BD Declares Increased Dividend
11/22/1999
BD Announces Edward J. Ludwig Elected to the Board of Directors and CEO
11/04/1999
Becton Dickinson Announces Record Revenues for Fiscal Year
10/13/1999
BD Announces Chief Financial Officer Is Leaving the Company; External Search for Replacement Underway
08/31/1999
QIAGEN and Becton, Dickinson and Company Agree to Form Joint Venture
08/30/1999
BD Acquires Saf-T-Med Advanced Safety Needle Technology
08/26/1999
Becton, Dickinson and Company Completes Acquisition of Clontech Laboratories, Inc.
08/09/1999
Becton, Dickinson and Company Announces Revised Agreement for Acquisition of Clontech Laboratories, Inc.
07/27/1999
Becton Dickinson Declares Dividend
07/21/1999
Becton Dickinson Reports Third Quarter Results; Charges Reduce Net Income by $69 Million
06/14/1999
Becton Dickinson And Company Says Full Year Results Likely To Be Below Expectations; Also Says Voluntary Retirement Program And Other Charges For June Quarter Expected To Be $75-$100 Million
05/25/1999
Becton Dickinson Declares Dividend
04/21/1999
Becton Dickinson Reports 18 Percent Revenue Increase for Fiscal Second Quarter
02/09/1999
Becton Dickinson and Company Announces the Acquisition of Biometric Imaging
01/26/1999
Becton Dickinson Declares Dividend
01/21/1999
Becton Dickinson Reports 16 Percent E.P.S. Increase for Fiscal First Quarter; Revenues Increase 10 Percent
12/14/1998
Becton Dickinson Acquires New Advanced Protection Technology
11/23/1998
Becton Dickinson Declares Increased Dividend
11/05/1998
Becton Dickinson Announces Record Revenues for Fiscal Year
07/28/1998
Becton Dickinson Declares Stock Split and Quarterly Dividend
07/21/1998
Becton Dickinson Reports Third Quarter Results; Record Revenues Increase 18 Percent; Charges Reduce Net Income by $106 Million
05/20/1998
Becton Dickinson Announces Election of Alfred Sommer to Board of Directors
05/19/1998
Becton Dickinson and Company Announces Restructuring Plan, One-Time Charges For Third Fiscal Quarter
05/19/1998
Becton Dickinson Declares Dividend
04/21/1998
Becton Dickinson Reports 13 Percent E.P.S. Increase for Fiscal Second Quarter
01/29/1998
Becton Dickinson And Company Signs Definitive Agreement To Acquire Medical Devices Division Of The BOC Group
01/27/1998
Becton Dickinson Declares Dividend
01/22/1998
Becton Dickinson Announces Record Fiscal First Quarter Results
11/25/1997
Becton Dickinson Declares Increased Dividend
11/06/1997
Becton Dickinson Announces Record Results for Fiscal Year